Physicochemical Stability of a Novel Tacrolimus Ophthalmic Formulation for the Treatment of Ophthalmic Inflammatory Diseases

Tacrolimus is an immunosuppressant used to treat a large variety of inflammatory or immunity-mediated ophthalmic diseases. However, there are currently no commercial industrial forms available that can provide relief to patients. Various ophthalmic formulations have been reported in the literature,...

Descripción completa

Detalles Bibliográficos
Autores principales: Barrieu, Marion, Chennell, Philip, Yessaad, Mouloud, Bouattour, Yassine, Wasiak, Mathieu, Jouannet, Mireille, Le Basle, Yoann, Sautou, Valérie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778879/
https://www.ncbi.nlm.nih.gov/pubmed/35057013
http://dx.doi.org/10.3390/pharmaceutics14010118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778879/
https://www.ncbi.nlm.nih.gov/pubmed/35057013
http://dx.doi.org/10.3390/pharmaceutics14010118

Ejemplares similares